Skip to main content
Top

1988 | OriginalPaper | Chapter

Medical Applications of Silver Halide Optical Fibers

Authors : Dov Gal, Abraham Katzir

Published in: LASER Optoelectronics in Medicine

Publisher: Springer Berlin Heidelberg

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Since the early eighties, when lasers were first used in cardiology, Intensive investigation has been carried on to develop a system consisting of a laser and an optical fiber for percutaneous transluminal laser angioplasty. Argon and Nd:YAG lasers were first used, since quartz fibers capable of transmitting visible light were commercially available (1). A persistent high rate of arterial wall perforation has jeopardized in vivo experiments with these two lasers. This arterial wall perforat ion has been attributed to the thermal mechanism by which the tissue was ablated (2). In the last two years it has been demonstrated that lasers such as dye, excimer, CO2 TEA and Er:YAG -emitting ultrashort, energetic pulses of light, which are strongly absorbed by tissue — should be selected to obtain tissue ablation with minimal thermal damage (3–5). Yet excimer laser pulses shorter than 300 nanometer are poorly transmitted through fused silica optical fibers, while good optical fibers for the transmission of the Er:YAG light at 2.43 micrometer are not yet commercially available. The CO2 laser was also considered a good candidate for cardiovascular applications. As a system, the CO2 laser is extremely well developed, featuring continuous (CW), chopped and pulse modes of energy delivery and almost an unlimited variety of energy profiles in the pulsed mode including ultrashort high energy pulses. The lasers are small, efficient, reliable, easy to operate and thus do not require high technical skills.

Metadata
Title
Medical Applications of Silver Halide Optical Fibers
Authors
Dov Gal
Abraham Katzir
Copyright Year
1988
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-642-72870-9_14

Premium Partners